Rocket


News + Filings
IR Vault





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
CC transcript
Inv. presentation
Appointed director
Director departure
Credit agrmnt [a]
Asset disposition
Acq. announced
Appointed CFO
Consulting agrmnt
Auditor change
Notes underwriting agrmnt
Director comp.
Employment agrmnt
Dividend declared
Appointed COO
Filed Chapter 11
Monthly dividend
Preliminary results
Accel. buyback
Cert. of designation
Acq. completed
Monthly oper. report
Merger agrmnt [a]
Quarterly results presentation
Class action filed
CFO resigned
Departure of a VP
SSS news release
Asset acq. complete
Letter to company
Buyback announced
Bonus plan approved
Upcoming conference date
Notes have priced
Coll. bargaining agrmnt
10-Q late filing
RE purchase
Amended bylaws
New credit facility

All Companies Create: Portfolio | Alert

All | News | Filings
Date Filed  SymbolTypeDescription
02/15/2017    IOTS 8-K Form 8-K - Current report
04/27/2016    UONE 8-K Bonus plan approved/adopted
Docs: "Credit Agreement, among Radio One, Inc., the lenders party thereto from time to time and Wells Fargo Bank National Association, as administrative agent",
"Extension Agreement attaching to and made a part of Employment Agreement by and between Radio One, Inc. and Peter D. Thompson"
03/03/2015    CWST 8-K Bonus plan approved/adopted
Docs: "Loan and Security Agreement, among Casella Waste Systems, Inc., the subsidiaries of Casella Waste Systems, Inc. identified therein and Bank of America, N.A., as agent for the lenders party thereto"
12/08/2014    CBST 8-K Bonus plan approved/adopted
Docs: "Agreement and Plan of Merger, among Merck & Co., Inc., Mavec Corporation and Cubist Pharmaceuticals, Inc. Schedules to the Agreement and Plan of Merger have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant will furnish copies of any such schedules to the U.S. Securities and Exchange Commission upon request",
"Amended and Restated Bylaws of Cubist Pharmaceuticals, Inc. (marked)",
"Cubist Pharmaceuticals, Inc. 2014 Severance Plan and Summary Plan Description",
"Merck to Acquire Cubist Pharmaceuticals for $102 Per Share in Cash Acquisition Augments Merck's Strong Foundation and Opportunity for Growth in Hospital Acute Care Market"
11/09/2006    ARBA 8-K Bonus plan approved/adopted
04/17/2006    ASVI 8-K Bonus plan approved/adopted
Docs: "Employment and Supplement Executive Retirement Pay Agreement between Mark Glasnapp and A.S.V., Inc., effective as of July 12, 2004"
03/31/2006    LF 8-K Bonus plan approved/adopted
03/23/2006    PLAY 8-K Bonus plan approved/adopted
03/09/2006    RTIX 8-K Form 8-K - Current report
02/28/2006    ****** 8-K Bonus plan approved/adopted
Docs: "Executive Officer Salaries and 2006 Bonus Plan"
02/28/2006    PSYS 8-K Bonus plan approved/adopted
Docs: "Psychiatric Solutions, Inc. Cash Bonus Plans",
"Psychiatric Solutions, Inc. 2006 Long-Term Equity Compensation Plan"
10/06/2005    INFT 8-K Bonus plan approved/adopted
09/08/2005    PRSF 8-K Bonus plan approved/adopted
08/01/2005    RTIX 8-K Form 8-K - Current report
07/21/2005    GROW 8-K Form 8-K - Current report
03/23/2005    SWRF 8-K Form 8-K - Current report
12/15/2004    HDSN 8-K Bonus plan approved/adopted
09/29/2004    JOB 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy